Advanced Drainage Systems Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Advanced Drainage Systems Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities | 71,055,000 | 45,708,000 | -132,000 | 112,517,000 | 35,066,000 | -18,142,000 | 74,597,000 | 32,065,000 | -21,258,000 | ||||||||||||||||||||||||||||||||||||
net income | 144,091,000 | 76,788,000 | 82,289,000 | 131,174,000 | 162,322,000 | 95,479,000 | 106,880,000 | 137,027,000 | 173,905,000 | 86,312,000 | 83,182,000 | 153,377,000 | 188,482,000 | 47,129,000 | 74,462,000 | 76,312,000 | 77,123,000 | 20,776,000 | 54,041,000 | 80,605,000 | 70,668,000 | 3,533,000 | 23,659,000 | 8,462,000 | -227,451,000 | 1,893,000 | 16,550,000 | 29,372,000 | 33,651,000 | -4,856,000 | 33,215,000 | 17,959,000 | 18,474,000 | ||||||||||||
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||||||||||||||||||||||||||||
depreciation and amortization | 50,228,000 | 49,610,000 | 47,766,000 | 44,807,000 | 41,098,000 | 42,889,000 | 38,053,000 | 36,721,000 | 37,240,000 | 37,803,000 | 35,846,000 | 35,922,000 | 35,578,000 | 38,121,000 | 34,837,000 | 34,194,000 | 34,656,000 | 38,265,000 | 35,762,000 | 35,778,000 | 35,781,000 | 50,508,000 | 31,172,000 | 26,566,000 | 16,694,000 | 18,988,000 | 17,549,000 | 17,536,000 | 17,827,000 | 19,210,000 | 17,852,000 | 19,720,000 | 18,221,000 | ||||||||||||
deferred income taxes | -3,748,000 | -933,000 | 2,780,000 | -1,328,000 | -942,000 | -2,615,000 | -184,000 | -54,000 | 573,000 | -5,690,000 | -1,048,000 | -1,845,000 | -1,272,000 | -4,068,000 | 6,228,000 | -49,000 | 64,000 | -5,445,000 | -4,586,000 | -1,089,000 | -2,357,000 | -1,826,000 | -2,225,000 | -1,064,000 | 2,191,000 | 10,497,000 | -905,000 | 1,492,000 | 1,729,000 | 1,499,000 | -11,937,000 | -520,000 | -281,000 | ||||||||||||
loss on disposal of assets and costs from exit and disposal activities | 7,024,000 | 1,021,000 | 980,000 | 627,000 | 1,647,000 | 872,000 | 1,755,000 | 2,004,000 | 707,000 | 2,075,000 | 144,000 | 324,000 | 1,104,000 | 2,187,000 | 1,924,000 | 5,121,000 | 3,423,000 | ||||||||||||||||||||||||||||
stock-based compensation | 8,404,000 | 4,823,000 | 7,798,000 | 6,983,000 | 6,977,000 | 7,402,000 | 9,331,000 | 6,903,000 | |||||||||||||||||||||||||||||||||||||
amortization of deferred financing charges | 511,000 | 511,000 | 511,000 | 511,000 | 511,000 | 511,000 | 511,000 | 511,000 | 511,000 | 510,000 | 511,000 | 54,000 | 344,000 | 96,000 | 95,000 | 96,000 | 95,000 | 89,000 | 96,000 | 99,000 | 98,000 | 96,000 | 95,000 | 34,111,000 | 174,000 | 174,000 | 174,000 | 196,000 | 191,000 | 188,000 | 196,000 | 197,000 | 353,000 | ||||||||||||
fair market value adjustments to derivatives | 77,000 | -163,000 | -641,000 | 979,000 | 45,000 | -810,000 | 1,727,000 | -1,853,000 | -36,000 | 1,330,000 | 126,000 | 2,273,000 | -90,000 | -1,510,000 | 564,000 | 229,000 | -675,000 | -818,000 | -1,082,000 | -373,000 | -1,082,000 | 2,225,000 | -93,000 | -793,000 | 1,789,000 | 370,000 | 2,877,000 | -276,000 | -625,000 | -1,256,000 | -1,398,000 | -781,000 | 191,000 | ||||||||||||
equity in net income of unconsolidated affiliates | -1,343,000 | -734,000 | -818,000 | -918,000 | -1,701,000 | -1,656,000 | -1,304,000 | -901,000 | -1,675,000 | -1,137,000 | -639,000 | -1,956,000 | -1,110,000 | -458,000 | -717,000 | -206,000 | -205,000 | 390,000 | -67,000 | -173,000 | |||||||||||||||||||||||||
other operating activities | 809,000 | 1,551,000 | 4,275,000 | -2,370,000 | -3,754,000 | 977,000 | 4,964,000 | 255,000 | 501,000 | -1,219,000 | 3,445,000 | 2,822,000 | -3,535,000 | -1,781,000 | -10,339,000 | -9,000 | 450,000 | 608,000 | 6,398,000 | -505,000 | 269,000 | 8,000 | -2,378,000 | -755,000 | -2,880,000 | -1,726,000 | -2,151,000 | -312,000 | -1,030,000 | -11,036,000 | -32,000 | 13,734,000 | -1,656,000 | ||||||||||||
changes in working capital: | |||||||||||||||||||||||||||||||||||||||||||||
receivables | -42,126,000 | -81,645,000 | 118,624,000 | 11,426,000 | -46,991,000 | -81,820,000 | 110,760,000 | -10,124,000 | -33,406,000 | -62,471,000 | 143,638,000 | 35,936,000 | -79,616,000 | -37,169,000 | 78,242,000 | -70,675,000 | -67,388,000 | -47,262,000 | 72,608,000 | -18,013,000 | -42,093,000 | -45,695,000 | 95,748,000 | -389,000 | -44,494,000 | -34,721,000 | 81,417,000 | -9,739,000 | -54,910,000 | 10,490,000 | 96,646,000 | -63,994,000 | -47,469,000 | ||||||||||||
inventories | 40,001,000 | -15,570,000 | 24,571,000 | 275,000 | -25,025,000 | -59,158,000 | -19,463,000 | 48,355,000 | 30,860,000 | -4,647,000 | 19,072,000 | 7,760,000 | 8,039,000 | -27,837,000 | -37,449,000 | -95,444,000 | -28,985,000 | -61,370,000 | -13,854,000 | 16,523,000 | 44,140,000 | -24,231,000 | -13,999,000 | 22,513,000 | 34,803,000 | -17,739,000 | -673,000 | 15,338,000 | 1,040,000 | -49,401,000 | -1,645,000 | 48,650,000 | -2,445,000 | ||||||||||||
prepaid expenses and other current assets | -5,945,000 | -1,419,000 | 2,240,000 | -1,078,000 | -3,726,000 | 259,000 | 1,694,000 | 1,471,000 | -3,699,000 | -764,000 | 3,244,000 | -2,936,000 | -4,840,000 | 557,000 | 1,539,000 | 704,000 | -7,442,000 | 1,080,000 | 1,378,000 | -146,000 | -3,520,000 | -512,000 | 1,500,000 | 172,000 | -3,089,000 | 1,558,000 | -446,000 | 1,549,000 | -3,665,000 | -457,000 | 1,849,000 | 2,803,000 | -2,547,000 | ||||||||||||
accounts payable, accrued expenses, and other liabilities | 76,994,000 | -98,980,000 | -24,178,000 | 54,320,000 | -12,154,000 | -5,965,000 | 45,594,000 | -69,794,000 | -51,506,000 | 101,209,000 | -75,422,000 | 28,648,000 | 75,860,000 | -7,848,000 | 24,370,000 | 17,893,000 | -24,116,000 | 3,817,000 | 30,653,000 | -28,591,000 | -13,888,000 | 8,806,000 | -29,759,000 | -2,888,000 | -6,857,000 | ||||||||||||||||||||
net cash from operating activities | 274,977,000 | 41,227,000 | 189,938,000 | 166,900,000 | 183,426,000 | 17,666,000 | 241,398,000 | 214,897,000 | 243,967,000 | 47,372,000 | 223,414,000 | 187,259,000 | 249,765,000 | 81,041,000 | 98,969,000 | -9,470,000 | 104,348,000 | 3,440,000 | 162,608,000 | 152,435,000 | 133,733,000 | 9,871,000 | 124,607,000 | 108,871,000 | 62,840,000 | 3,656,000 | 89,861,000 | 48,330,000 | 9,831,000 | -1,789,000 | 110,520,000 | 44,926,000 | -16,537,000 | ||||||||||||
cash flows from investing activities | |||||||||||||||||||||||||||||||||||||||||||||
capital expenditures | -52,598,000 | -46,534,000 | -54,228,000 | -54,467,000 | -57,715,000 | -47,427,000 | -53,760,000 | -40,547,000 | -42,078,000 | -40,055,000 | -51,313,000 | -39,356,000 | -36,189,000 | -48,716,000 | -36,603,000 | -38,218,000 | -25,546,000 | -21,082,000 | -28,716,000 | -18,664,000 | -10,295,000 | -21,384,000 | -20,671,000 | -15,899,000 | -9,723,000 | -12,282,000 | -11,831,000 | -12,425,000 | -6,874,000 | -6,585,000 | -8,089,000 | -9,086,000 | -17,949,000 | -10,172,000 | -12,708,000 | -11,201,000 | -12,595,000 | -14,972,000 | -9,773,000 | -9,602,000 | -10,595,000 | -10,002,000 | -5,834,000 | -8,193,000 | -7,450,000 |
free cash flows | 222,379,000 | -5,307,000 | 135,710,000 | 112,433,000 | 125,711,000 | -29,761,000 | 187,638,000 | 174,350,000 | 201,889,000 | 7,317,000 | 172,101,000 | 147,903,000 | 213,576,000 | 32,325,000 | 62,366,000 | -47,688,000 | 78,802,000 | -17,642,000 | 133,892,000 | 133,771,000 | 123,438,000 | -11,513,000 | 103,936,000 | 92,972,000 | 53,117,000 | -8,626,000 | 78,030,000 | 35,905,000 | 2,957,000 | -8,374,000 | 102,431,000 | 35,840,000 | -34,486,000 | ||||||||||||
acquisition, net of cash acquired | -19,576,000 | 0 | 0 | 0 | -518,000 | -47,492,000 | -99,000 | ||||||||||||||||||||||||||||||||||||||
other investing activities | 2,240,000 | 1,557,000 | 191,000 | 142,000 | 498,000 | 123,000 | 81,000 | 291,000 | 155,000 | 400,000 | 0 | 33,000 | 13,000 | 22,000 | -2,019,000 | 1,503,000 | 53,000 | 367,000 | 61,000 | 20,000 | 435,000 | 6,776,000 | -131,000 | -103,000 | -13,000 | -241,000 | 680,000 | 538,000 | -109,000 | 180,000 | -159,000 | -157,000 | -254,000 | -589,000 | -179,000 | -422,000 | -200,000 | -147,000 | -363,000 | -206,000 | -172,000 | 2,229,000 | -2,304,000 | -215,000 | -310,000 |
net cash from investing activities | -69,934,000 | -44,977,000 | -291,347,000 | -54,325,000 | -57,217,000 | -39,785,000 | -53,679,000 | -40,256,000 | -21,944,000 | -39,655,000 | -51,313,000 | -39,841,000 | -83,668,000 | -48,793,000 | -87,832,000 | -36,715,000 | -25,493,000 | -20,715,000 | -28,655,000 | -18,644,000 | -9,860,000 | -14,608,000 | -21,507,000 | -1,104,619,000 | -9,736,000 | -12,523,000 | -11,151,000 | -11,887,000 | -6,983,000 | 1,280,000 | -2,289,000 | -11,233,000 | -18,203,000 | -19,838,000 | -17,003,000 | -11,623,000 | -12,795,000 | -13,615,000 | -10,303,000 | -9,539,000 | -15,561,000 | -44,221,000 | -6,130,000 | -9,096,000 | -16,646,000 |
cash flows from financing activities | |||||||||||||||||||||||||||||||||||||||||||||
payments on syndicated term loan facility | -1,750,000 | -1,750,000 | -1,750,000 | -1,750,000 | -1,750,000 | -1,750,000 | -1,750,000 | -1,750,000 | -1,750,000 | -1,750,000 | -1,750,000 | -1,750,000 | -1,750,000 | -1,750,000 | -1,750,000 | -1,750,000 | -1,750,000 | -1,750,000 | -101,750,000 | -101,750,000 | -1,750,000 | -1,750,000 | |||||||||||||||||||||||
payments on equipment financing | -933,000 | -988,000 | -1,244,000 | -1,323,000 | -1,342,000 | -1,377,000 | -1,903,000 | -2,202,000 | -2,256,000 | -2,319,000 | -3,109,000 | -3,556,000 | -3,548,000 | -3,538,000 | |||||||||||||||||||||||||||||||
payments on finance lease obligations | -8,335,000 | -7,667,000 | -6,064,000 | -6,243,000 | -5,513,000 | -3,521,000 | -3,172,000 | -2,683,000 | -2,769,000 | -2,732,000 | -1,801,000 | -1,432,000 | -1,721,000 | -1,082,000 | -38,928,000 | -5,058,000 | -5,379,000 | -5,632,000 | -5,182,000 | -4,977,000 | -5,700,000 | -8,695,000 | -6,049,000 | -6,328,000 | -6,047,000 | ||||||||||||||||||||
repurchase of common stock | 0 | 0 | -20,677,000 | -49,245,000 | -29,121,000 | -76,623,000 | -53,786,000 | -47,778,000 | -200,000,000 | -182,425,000 | -134,903,000 | -57,699,000 | 0 | 0 | -189,987,000 | -102,013,000 | 0 | 0 | 0 | -7,947,000 | |||||||||||||||||||||||||
cash dividends paid | -13,980,000 | -12,413,000 | -12,407,000 | -12,489,000 | -12,428,000 | -10,884,000 | -10,887,000 | -11,140,000 | -11,084,000 | -9,501,000 | -9,744,000 | -10,197,000 | -10,170,000 | -10,668,000 | -9,068,000 | -9,307,000 | -9,451,000 | -7,648,000 | -9,105,000 | -7,665,000 | -7,737,000 | -8,281,000 | -7,522,000 | -6,683,000 | -69,641,000 | -5,064,000 | -9,466,000 | -5,477,000 | -6,141,000 | -4,967,000 | -4,838,000 | -4,320,000 | -4,353,000 | -5,809,000 | -3,673,000 | -3,673,000 | -3,665,000 | -3,569,000 | -4,498,000 | -4,389,000 | -3,784,000 | -5,486,000 | |||
proceeds from exercise of stock options | 549,000 | 233,000 | 1,716,000 | 6,978,000 | 1,333,000 | 1,756,000 | 867,000 | 485,000 | 3,411,000 | 1,249,000 | 1,095,000 | 1,843,000 | 1,336,000 | 714,000 | 1,036,000 | 2,239,000 | 3,850,000 | 917,000 | 1,513,000 | 464,000 | 258,000 | 3,215,000 | 7,506,000 | 94,000 | 6,000 | 0 | 39,000 | 2,648,000 | |||||||||||||||||
payment of withholding taxes on vesting of restricted stock units | -6,683,000 | -11,000 | -70,000 | -18,000 | -10,558,000 | -5,000 | -48,000 | -69,000 | -8,742,000 | -10,000 | -3,141,000 | -2,703,000 | -22,809,000 | -8,000 | -79,000 | 0 | -12,976,000 | ||||||||||||||||||||||||||||
other financing activities | 39,000 | -37,000 | -19,000 | 63,000 | -99,000 | -131,000 | -1,000 | 0 | -1,000 | 0 | 22,000 | -258,000 | 559,000 | -359,000 | -304,000 | -257,000 | -870,000 | -387,000 | -519,000 | -652,000 | 356,000 | -719,000 | -612,000 | -8,000 | 1,505,000 | -223,000 | -133,000 | 587,000 | 2,183,000 | -437,000 | -392,000 | -40,000 | |||||||||||||
net cash from financing activities | -31,132,000 | -21,783,000 | -21,304,000 | -40,745,000 | -73,895,000 | -47,907,000 | -93,050,000 | -69,874,000 | -73,512,000 | -217,688,000 | -203,410,000 | -152,857,000 | 277,677,000 | -34,494,000 | -2,981,000 | -82,272,000 | -131,321,000 | -11,467,000 | -115,323,000 | -164,845,000 | -62,948,000 | 83,156,000 | -59,721,000 | 1,040,770,000 | -52,633,000 | -2,276,000 | -76,289,000 | -37,492,000 | -1,598,000 | -424,000 | -100,703,000 | -31,021,000 | 37,195,000 | 26,245,000 | -50,259,000 | -35,013,000 | 16,202,000 | 6,852,000 | -97,490,000 | -27,071,000 | 34,745,000 | 48,034,000 | -64,079,000 | -20,957,000 | 38,793,000 |
effect of exchange rate changes on cash | 1,098,000 | 51,000 | -1,384,000 | -350,000 | -792,000 | -472,000 | 1,268,000 | -462,000 | 465,000 | 409,000 | 642,000 | -900,000 | -203,000 | 198,000 | 12,000 | -371,000 | 290,000 | -245,000 | 1,483,000 | -273,000 | 52,000 | -2,498,000 | 726,000 | -172,000 | -5,000 | 276,000 | -275,000 | 267,000 | -443,000 | 113,000 | -304,000 | -206,000 | -188,000 | 338,000 | -500,000 | 564,000 | -662,000 | 182,000 | |||||||
net change in cash | 175,009,000 | -25,482,000 | -124,097,000 | 71,480,000 | 51,522,000 | -70,498,000 | 95,937,000 | 104,305,000 | 148,976,000 | -209,562,000 | -30,667,000 | -6,339,000 | 443,571,000 | -2,048,000 | 8,168,000 | -128,828,000 | -52,176,000 | -28,987,000 | 20,113,000 | -31,327,000 | 60,977,000 | 75,921,000 | 44,105,000 | 44,850,000 | 466,000 | -10,867,000 | 2,146,000 | -782,000 | 807,000 | -820,000 | 7,224,000 | 2,466,000 | 2,267,000 | -5,647,000 | 3,293,000 | -364,000 | 2,613,000 | 143,000 | 2,931,000 | -1,366,000 | 1,224,000 | ||||
cash and restricted cash at beginning of period | 469,271,000 | 0 | 0 | 495,848,000 | |||||||||||||||||||||||||||||||||||||||||
cash and restricted cash at end of period | 644,280,000 | -124,097,000 | 71,480,000 | 547,370,000 | |||||||||||||||||||||||||||||||||||||||||
reconciliation to balance sheet | |||||||||||||||||||||||||||||||||||||||||||||
cash | 638,268,000 | -25,540,000 | -124,161,000 | 71,383,000 | 541,637,000 | -70,581,000 | |||||||||||||||||||||||||||||||||||||||
restricted cash | 6,012,000 | 58,000 | 64,000 | 97,000 | 5,733,000 | 83,000 | |||||||||||||||||||||||||||||||||||||||
total cash and restricted cash | 644,280,000 | -25,482,000 | -124,097,000 | 71,480,000 | 547,370,000 | -70,498,000 | |||||||||||||||||||||||||||||||||||||||
balance at april 1, 2024 | 82,283,000 | 82,283,000 | |||||||||||||||||||||||||||||||||||||||||||
other comprehensive loss | |||||||||||||||||||||||||||||||||||||||||||||
common stock dividends | |||||||||||||||||||||||||||||||||||||||||||||
share repurchases | |||||||||||||||||||||||||||||||||||||||||||||
ksop redeemable common stock conversion | 296,000 | 1,875,000 | -208,000 | 629,000 | 297,000 | -1,608,000 | 1,376,000 | 403,000 | |||||||||||||||||||||||||||||||||||||
exercise of common stock options | 197,000 | 191,000 | 6,000 | 14,000 | 21,000 | 189,000 | -99,000 | 49,000 | 67,000 | 297,000 | -5,000 | 28,000 | 48,000 | 542,000 | -30,000 | -34,000 | 93,000 | 147,000 | 219,000 | -60,000 | 114,000 | 631,000 | 10,000 | -192,000 | 217,000 | ||||||||||||||||||||
restricted stock awards | 79,000 | 175,000 | -22,000 | -53,000 | 76,000 | 125,000 | 61,000 | -64,000 | 81,000 | 132,000 | -28,000 | -69,000 | 99,000 | 114,000 | -56,000 | -10,000 | 70,000 | 125,000 | -55,000 | 26,000 | 31,000 | 16,000 | 19,000 | ||||||||||||||||||||||
performance-based restricted stock units | 93,000 | 327,000 | 0 | 0 | 200,000 | -282,000 | 0 | 0 | 527,000 | 0 | 0 | 0 | 245,000 | ||||||||||||||||||||||||||||||||
stock-based compensation expense | |||||||||||||||||||||||||||||||||||||||||||||
espp share issuance | 25,000 | 25,000 | |||||||||||||||||||||||||||||||||||||||||||
other | |||||||||||||||||||||||||||||||||||||||||||||
balance at june 30, 2024 | 82,973,000 | 82,973,000 | |||||||||||||||||||||||||||||||||||||||||||
balance at april 1, 2025 | 83,750,000 | ||||||||||||||||||||||||||||||||||||||||||||
other comprehensive income | |||||||||||||||||||||||||||||||||||||||||||||
balance at june 30, 2025 | 84,247,000 | ||||||||||||||||||||||||||||||||||||||||||||
gain on disposal of assets and costs from exit and disposal activities | 3,426,000 | -477,000 | 617,000 | 292,000 | 303,000 | ||||||||||||||||||||||||||||||||||||||||
accounts payable, accrued expenses and other liabilities | |||||||||||||||||||||||||||||||||||||||||||||
proceeds from disposition of assets or businesses | |||||||||||||||||||||||||||||||||||||||||||||
proceeds from revolving credit agreement | 0 | 0 | 0 | 26,200,000 | 74,100,000 | 111,300,000 | 100,000,000 | 0 | |||||||||||||||||||||||||||||||||||||
payments on revolving credit agreement | 0 | 0 | 0 | -140,500,000 | -93,300,000 | -100,400,000 | 0 | 0 | -50,000,000 | -50,000,000 | 0 | 0 | |||||||||||||||||||||||||||||||||
proceeds from amended revolving credit agreement | 0 | 0 | 0 | 97,000,000 | |||||||||||||||||||||||||||||||||||||||||
payments on amended revolving credit agreement | 0 | 0 | 0 | -97,000,000 | |||||||||||||||||||||||||||||||||||||||||
proceeds from senior notes due 2030 | 0 | 0 | 0 | 500,000,000 | |||||||||||||||||||||||||||||||||||||||||
debt issuance costs | 0 | 0 | 0 | -11,575,000 | 0 | 0 | 0 | 0 | 0 | -2,268,000 | |||||||||||||||||||||||||||||||||||
dividends paid to noncontrolling interest holder | -1,671,000 | -1,925,000 | 0 | -514,000 | -957,000 | ||||||||||||||||||||||||||||||||||||||||
proceeds from option exercises | |||||||||||||||||||||||||||||||||||||||||||||
cash at beginning of year | |||||||||||||||||||||||||||||||||||||||||||||
cash and restricted cash at end of year | |||||||||||||||||||||||||||||||||||||||||||||
balance april 1, 2022 | |||||||||||||||||||||||||||||||||||||||||||||
common stock dividend | |||||||||||||||||||||||||||||||||||||||||||||
dividend paid to noncontrolling interest holder | |||||||||||||||||||||||||||||||||||||||||||||
esop share conversion | |||||||||||||||||||||||||||||||||||||||||||||
balance march 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||
proceeds from disposition of assets | 0 | 0 | 19,979,000 | ||||||||||||||||||||||||||||||||||||||||||
balance at october 1, 2023 | |||||||||||||||||||||||||||||||||||||||||||||
balance at december 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||
balance at april 1, 2023 | 0 | 0 | 79,057,000 | 79,057,000 | |||||||||||||||||||||||||||||||||||||||||
balance at july 1, 2023 | |||||||||||||||||||||||||||||||||||||||||||||
balance at september 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||
balance at june 30, 2023 | 79,651,000 | 79,651,000 | |||||||||||||||||||||||||||||||||||||||||||
(gain) loss on disposal of assets and costs from exit and disposal activities | 123,000 | -13,304,000 | -348,000 | -901,000 | -11,000 | ||||||||||||||||||||||||||||||||||||||||
esop and stock-based compensation | 1,747,000 | 6,179,000 | 7,460,000 | 6,273,000 | 15,659,000 | 23,463,000 | 17,631,000 | 20,806,000 | 20,021,000 | 18,325,000 | 14,626,000 | 12,462,000 | 5,030,000 | 11,283,000 | 8,657,000 | 7,425,000 | 4,382,000 | 6,180,000 | 5,580,000 | 4,377,000 | 4,405,000 | 4,304,000 | |||||||||||||||||||||||
esop acceleration | |||||||||||||||||||||||||||||||||||||||||||||
proceeds from equipment financing | 0 | ||||||||||||||||||||||||||||||||||||||||||||
balance april 1, 2021 | |||||||||||||||||||||||||||||||||||||||||||||
redeemable convertible preferred stock dividends | |||||||||||||||||||||||||||||||||||||||||||||
allocation of esop shares to participants for: | |||||||||||||||||||||||||||||||||||||||||||||
compensation | |||||||||||||||||||||||||||||||||||||||||||||
dividend | |||||||||||||||||||||||||||||||||||||||||||||
esop distributions in common stock | |||||||||||||||||||||||||||||||||||||||||||||
balance march 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||
balance at october 1, 2022 | |||||||||||||||||||||||||||||||||||||||||||||
balance at december 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||
balance at april 1, 2022 | 0 | 0 | 75,529,000 | ||||||||||||||||||||||||||||||||||||||||||
cash at beginning of period | 0 | 217,128,000 | 0 | 0 | 20,125,000 | 0 | 0 | 195,009,000 | 0 | 0 | 174,233,000 | 0 | 0 | 8,891,000 | 0 | 0 | 17,587,000 | 0 | 0 | 6,450,000 | 0 | 0 | 6,555,000 | 0 | 0 | 3,623,000 | |||||||||||||||||||
cash at end of period | 104,305,000 | 366,104,000 | -30,667,000 | -6,339,000 | 463,696,000 | 8,168,000 | -128,828,000 | 142,833,000 | 20,113,000 | -31,327,000 | 235,210,000 | 44,105,000 | 44,850,000 | 9,357,000 | 2,146,000 | -782,000 | 18,394,000 | 7,224,000 | 2,466,000 | 8,717,000 | 3,293,000 | -364,000 | 9,168,000 | 2,931,000 | -1,366,000 | 4,847,000 | |||||||||||||||||||
supplemental cash flow information | |||||||||||||||||||||||||||||||||||||||||||||
cash paid for income taxes | 76,747,000 | 1,553,000 | 34,850,000 | 96,415,000 | 5,055,000 | 19,215,000 | 59,208,000 | 2,605,000 | 25,131,000 | 2,251,000 | 6,664,000 | 535,000 | 9,128,000 | 17,379,000 | 952,000 | 3,239,000 | 16,270,000 | 5,899,000 | 1,030,000 | 896,000 | 2,229,000 | ||||||||||||||||||||||||
cash paid for interest | 24,965,000 | 8,499,000 | 6,481,000 | 13,562,000 | 4,714,000 | 4,697,000 | 11,669,000 | 3,714,000 | 4,382,000 | 13,989,000 | 6,934,000 | 6,221,000 | 13,851,000 | 3,920,000 | 3,474,000 | 4,032,000 | 4,000,000 | 4,480,000 | 4,926,000 | 4,498,000 | 3,868,000 | 4,413,000 | 4,996,000 | ||||||||||||||||||||||
non-cash operating, investing and financing activities: | |||||||||||||||||||||||||||||||||||||||||||||
repurchase of common stock pending settlement | -7,101,000 | 9,662,000 | |||||||||||||||||||||||||||||||||||||||||||
share repurchase excise tax accrual | 550,000 | 293,000 | |||||||||||||||||||||||||||||||||||||||||||
acquisition of property, plant and equipment under finance lease and incurred lease obligations | 8,883,000 | 944,000 | 4,003,000 | 4,927,000 | 1,754,000 | 4,855,000 | 2,021,000 | 9,382,000 | 1,580,000 | 1,441,000 | 1,278,000 | 296,000 | |||||||||||||||||||||||||||||||||
balance in accounts payable for the acquisition of property, plant and equipment | 5,418,000 | 19,781,000 | -883,000 | -1,250,000 | 16,881,000 | 4,814,000 | 4,921,000 | 6,578,000 | -657,000 | 328,000 | 3,772,000 | 460,000 | -695,000 | 4,364,000 | -771,000 | 1,301,000 | 1,851,000 | -377,000 | -1,218,000 | 2,593,000 | -1,090,000 | 2,255,000 | |||||||||||||||||||||||
balance at july 1, 2022 | |||||||||||||||||||||||||||||||||||||||||||||
balance at september 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||
balance at june 30, 2022 | 76,607,000 | ||||||||||||||||||||||||||||||||||||||||||||
cash at end of year | |||||||||||||||||||||||||||||||||||||||||||||
balance april 1, 2020 | |||||||||||||||||||||||||||||||||||||||||||||
adoption of asu 2016-13 | |||||||||||||||||||||||||||||||||||||||||||||
balance march 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||
balance at october 1, 2021 | |||||||||||||||||||||||||||||||||||||||||||||
allocation of esop shares to participants for compensation | |||||||||||||||||||||||||||||||||||||||||||||
esop distribution in common stock | 322,000 | 0 | 764,000 | 44,000 | 237,000 | -172,000 | 174,000 | 241,000 | -107,000 | 241,000 | |||||||||||||||||||||||||||||||||||
balance at december 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||
balance at april 1, 2021 | 0 | 0 | 72,071,000 | ||||||||||||||||||||||||||||||||||||||||||
balance at july 1, 2021 | |||||||||||||||||||||||||||||||||||||||||||||
balance at september 30, 2021 | |||||||||||||||||||||||||||||||||||||||||||||
balance at june 30, 2021 | 73,227,000 | ||||||||||||||||||||||||||||||||||||||||||||
esop acceleration and special dividend compensation | |||||||||||||||||||||||||||||||||||||||||||||
inventory step up related to infiltrator acquisition | |||||||||||||||||||||||||||||||||||||||||||||
proceeds from term loan facility | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||
payments on term loan facility | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||
proceeds from syndication of term loan facility | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||
proceeds from senior notes | 0 | 0 | 0 | 0 | 0 | 75,000,000 | |||||||||||||||||||||||||||||||||||||||
proceeds from pnc credit agreement | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||
payments on pnc credit agreement | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||
payments on prudential senior notes | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||
proceeds from common stock offering, net of offering costs | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||
balance april 1, 2019 | |||||||||||||||||||||||||||||||||||||||||||||
special dividend | |||||||||||||||||||||||||||||||||||||||||||||
common stock offering | 0 | ||||||||||||||||||||||||||||||||||||||||||||
balance march 31, 2020 | |||||||||||||||||||||||||||||||||||||||||||||
balance at october 1, 2020 | |||||||||||||||||||||||||||||||||||||||||||||
balance at december 31, 2020 | |||||||||||||||||||||||||||||||||||||||||||||
balance at april 1, 2020 | 0 | 0 | 69,810,000 | ||||||||||||||||||||||||||||||||||||||||||
balance at july 1, 2020 | |||||||||||||||||||||||||||||||||||||||||||||
balance at september 30, 2020 | |||||||||||||||||||||||||||||||||||||||||||||
repurchases of common stock pending settlement | 13,365,000 | ||||||||||||||||||||||||||||||||||||||||||||
common stock | |||||||||||||||||||||||||||||||||||||||||||||
shares | |||||||||||||||||||||||||||||||||||||||||||||
balance at june 30, 2020 | 69,973,000 | ||||||||||||||||||||||||||||||||||||||||||||
esop special dividend compensation | 0 | 0 | 0 | 246,752,000 | |||||||||||||||||||||||||||||||||||||||||
equity in net (income) loss of unconsolidated affiliates | 99,000 | -203,000 | -434,000 | -248,000 | |||||||||||||||||||||||||||||||||||||||||
acquisition of infiltrator, net of cash acquired | |||||||||||||||||||||||||||||||||||||||||||||
payments of notes, mortgages, and other debt | -25,000 | -91,000 | -3,875,000 | -3,217,000 | -2,955,000 | -283,000 | -1,348,000 | -317,000 | |||||||||||||||||||||||||||||||||||||
acquisition of noncontrolling interest in baysaver | 0 | ||||||||||||||||||||||||||||||||||||||||||||
balance april 1, 2018 | |||||||||||||||||||||||||||||||||||||||||||||
balance march 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||
inventory step up related to infiltrator water technologies acquisition | 0 | 2,107,000 | |||||||||||||||||||||||||||||||||||||||||||
acquisition of infiltrator water technologies, net of cash acquired | 0 | -705,000 | |||||||||||||||||||||||||||||||||||||||||||
balance at october 1, 2019 | |||||||||||||||||||||||||||||||||||||||||||||
balance at december 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||
balance at april 1, 2019 | 0 | 0 | 57,964,000 | 57,964,000 | |||||||||||||||||||||||||||||||||||||||||
'esop special dividend compensation | |||||||||||||||||||||||||||||||||||||||||||||
balance at july 1, 2019 | |||||||||||||||||||||||||||||||||||||||||||||
balance at september 30, 2019 | |||||||||||||||||||||||||||||||||||||||||||||
cash (refund) paid for income taxes | -19,000 | ||||||||||||||||||||||||||||||||||||||||||||
balance at june 30, 2019 | 58,283,000 | 58,283,000 | |||||||||||||||||||||||||||||||||||||||||||
payments on term loan | 0 | 0 | 0 | -72,500,000 | -2,500,000 | -2,500,000 | -2,500,000 | -2,500,000 | -2,500,000 | -2,500,000 | -1,875,000 | -1,875,000 | -1,875,000 | -1,875,000 | -1,250,000 | -1,250,000 | |||||||||||||||||||||||||||||
balance april 1, 2017 | |||||||||||||||||||||||||||||||||||||||||||||
other comprehensive gain | |||||||||||||||||||||||||||||||||||||||||||||
reclassification of liability-classified awards | |||||||||||||||||||||||||||||||||||||||||||||
retirement of common stock held in treasury | |||||||||||||||||||||||||||||||||||||||||||||
common stock repurchases | |||||||||||||||||||||||||||||||||||||||||||||
accretion of redeemable noncontrolling interest | |||||||||||||||||||||||||||||||||||||||||||||
balance march 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||
balance at october 1, 2018 | |||||||||||||||||||||||||||||||||||||||||||||
dividend paid to non-controlling interest holder | |||||||||||||||||||||||||||||||||||||||||||||
balance at december 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||
balance at april 1, 2018 | 0 | 0 | 56,889,000 | 0 | 0 | 56,889,000 | |||||||||||||||||||||||||||||||||||||||
balance at july 1, 2018 | |||||||||||||||||||||||||||||||||||||||||||||
balance at september 30, 2018 | |||||||||||||||||||||||||||||||||||||||||||||
proceeds from revolving credit facility | 137,400,000 | 74,100,000 | 81,500,000 | 148,700,000 | 101,400,000 | 90,400,000 | 61,500,000 | 123,000,000 | 212,950,000 | 97,000,000 | 79,800,000 | 121,600,000 | 114,000,000 | 86,400,000 | 69,900,000 | 122,400,000 | 130,400,000 | 139,000,000 | 75,440,000 | 83,760,000 | 91,000,000 | ||||||||||||||||||||||||
payments on revolving credit facility | -115,600,000 | -66,200,000 | -133,200,000 | -149,700,000 | -93,700,000 | -80,200,000 | -158,300,000 | -117,900,000 | -155,750,000 | -53,200,000 | -121,500,000 | -119,200,000 | -88,700,000 | -69,900,000 | -155,300,000 | -132,900,000 | -90,100,000 | -72,700,000 | -132,500,000 | -176,400,000 | -50,600,000 | ||||||||||||||||||||||||
payments of notes, mortgages and other debt | -235,000 | -235,000 | -230,000 | -225,000 | -225,000 | -1,225,000 | -220,000 | -215,000 | -215,000 | ||||||||||||||||||||||||||||||||||||
balance at june 30, 2018 | 57,366,000 | 57,366,000 | |||||||||||||||||||||||||||||||||||||||||||
esop, stock repurchase agreement and stock-based compensation | |||||||||||||||||||||||||||||||||||||||||||||
gain on bargain purchase of pti acquisition | |||||||||||||||||||||||||||||||||||||||||||||
cash paid for acquisitions, net of cash acquired | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||
purchase of property, plant and equipment through financing | |||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of corporate-owned life insurance | 7,685,000 | ||||||||||||||||||||||||||||||||||||||||||||
payments on senior notes | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||
proceeds from notes, mortgages, and other debt | -185,000 | ||||||||||||||||||||||||||||||||||||||||||||
payments on loans against corporate-owned life insurance | |||||||||||||||||||||||||||||||||||||||||||||
equipment financing loans | |||||||||||||||||||||||||||||||||||||||||||||
payments on capital lease obligations | -6,493,000 | -6,172,000 | -5,734,000 | -5,885,000 | -6,038,000 | -5,959,000 | -6,151,000 | -6,066,000 | -5,387,000 | -5,563,000 | -5,452,000 | -5,358,000 | |||||||||||||||||||||||||||||||||
balance april 1, 2016 | |||||||||||||||||||||||||||||||||||||||||||||
dividend paid to noncontrolling interestholder | |||||||||||||||||||||||||||||||||||||||||||||
equity classified stock-based compensation expense before related tax effects | |||||||||||||||||||||||||||||||||||||||||||||
tax benefit resulting from exercise of certain stock-based compensation awards | |||||||||||||||||||||||||||||||||||||||||||||
balance march 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||
equity in net income (income) of unconsolidated affiliates | 133,000 | ||||||||||||||||||||||||||||||||||||||||||||
acquisition of property, plant and equipment under capital lease and incurred lease obligations | 8,055,000 | 8,689,000 | 3,171,000 | 10,797,000 | 5,608,000 | 9,588,000 | 1,801,000 | 1,465,000 | 13,450,000 | ||||||||||||||||||||||||||||||||||||
payable recorded for business acquisition | 0 | ||||||||||||||||||||||||||||||||||||||||||||
contribution of net accounts receivable to the south american joint venture | |||||||||||||||||||||||||||||||||||||||||||||
balance at april 1, 2017 | 0 | 0 | 153,560,000 | 0 | 0 | 153,560,000 | |||||||||||||||||||||||||||||||||||||||
reclassification of liability- classified awards | |||||||||||||||||||||||||||||||||||||||||||||
equity classified stock-based compensation expense | |||||||||||||||||||||||||||||||||||||||||||||
balance at december 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||
balance at september 30, 2017 | |||||||||||||||||||||||||||||||||||||||||||||
balance at june 30, 2017 | 153,560,000 | 153,560,000 | |||||||||||||||||||||||||||||||||||||||||||
loss on purchase of non-controlling interest | |||||||||||||||||||||||||||||||||||||||||||||
proceeds from note receivable to related party | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||
issuance of note receivable to related party | 0 | 0 | 0 | -3,854,000 | |||||||||||||||||||||||||||||||||||||||||
balance april 1, 2015 | |||||||||||||||||||||||||||||||||||||||||||||
acquisition of redeemable noncontrolling interest | |||||||||||||||||||||||||||||||||||||||||||||
balance march 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||
purchases of property, plant and equipment through financing | |||||||||||||||||||||||||||||||||||||||||||||
equipment financing | |||||||||||||||||||||||||||||||||||||||||||||
balance at april 1, 2016 | 0 | 0 | 153,560,000 | 0 | 0 | 153,560,000 | |||||||||||||||||||||||||||||||||||||||
balance at december 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||
stock-based compensation expense before related tax effects | |||||||||||||||||||||||||||||||||||||||||||||
acquisition of property, plant and equipment under financing facility | |||||||||||||||||||||||||||||||||||||||||||||
balance at september 30, 2016 | |||||||||||||||||||||||||||||||||||||||||||||
balance at june 30, 2016 | 153,560,000 | 153,560,000 | |||||||||||||||||||||||||||||||||||||||||||
changes in working capital | |||||||||||||||||||||||||||||||||||||||||||||
investment in unconsolidated affiliates | |||||||||||||||||||||||||||||||||||||||||||||
payments on loans against csv life insurance policies | |||||||||||||||||||||||||||||||||||||||||||||
payments for deferred initial public offering costs | 20,000 | -2,041,000 | |||||||||||||||||||||||||||||||||||||||||||
proceeds from initial public offering of common stock, net of underwriter discounts and commissions | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||
purchase of treasury stock — common | |||||||||||||||||||||||||||||||||||||||||||||
balance april 1, 2014 | |||||||||||||||||||||||||||||||||||||||||||||
redemption of common shares to exercise stock options | |||||||||||||||||||||||||||||||||||||||||||||
tax benefit resulting from exercise of certain stock- based compensation awards | |||||||||||||||||||||||||||||||||||||||||||||
initial public offering | |||||||||||||||||||||||||||||||||||||||||||||
purchase of common stock | |||||||||||||||||||||||||||||||||||||||||||||
adjustments to redeemable convertible preferred stock fair value measurement | |||||||||||||||||||||||||||||||||||||||||||||
adjustments to redeemable common stock fair value measurement | |||||||||||||||||||||||||||||||||||||||||||||
termination of redemption feature upon ipo | |||||||||||||||||||||||||||||||||||||||||||||
adjustments to redeemable common stock agreements | |||||||||||||||||||||||||||||||||||||||||||||
balance march 31, 2015 | |||||||||||||||||||||||||||||||||||||||||||||
proceeds of note receivable to related party | |||||||||||||||||||||||||||||||||||||||||||||
proceeds from notes, mortgages and other debt | -244,000 | 6,926,000 | |||||||||||||||||||||||||||||||||||||||||||
balance at april 1, 2015 | 0 | 0 | 153,560,000 | 153,560,000 | |||||||||||||||||||||||||||||||||||||||||
balance at december 31, 2015 | |||||||||||||||||||||||||||||||||||||||||||||
balance at september 30, 2015 | |||||||||||||||||||||||||||||||||||||||||||||
balance at june 30, 2015 | 153,560,000 | 153,560,000 | |||||||||||||||||||||||||||||||||||||||||||
gain on disposal of assets or businesses | |||||||||||||||||||||||||||||||||||||||||||||
investment in unconsolidated affiliate | 0 | 0 | 0 | -7,566,000 | |||||||||||||||||||||||||||||||||||||||||
proceeds from term loan | |||||||||||||||||||||||||||||||||||||||||||||
payments on csv life insurance policies | |||||||||||||||||||||||||||||||||||||||||||||
payments on capital lease obligation | -4,874,000 | -4,659,000 | -6,055,000 | -4,192,000 | |||||||||||||||||||||||||||||||||||||||||
redemption of redeemable convertible preferred stock | |||||||||||||||||||||||||||||||||||||||||||||
balance april 1, 2013 | |||||||||||||||||||||||||||||||||||||||||||||
reclassification of common stock to redeemable common stock | |||||||||||||||||||||||||||||||||||||||||||||
balance march 31, 2014 | |||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of assets or businesses | |||||||||||||||||||||||||||||||||||||||||||||
additions of capitalized software | -167,000 | -397,000 | -940,000 | -688,000 | -1,320,000 | ||||||||||||||||||||||||||||||||||||||||
effect of exchange rate changes on cash and cash equivalents | -1,793,000 | -216,000 | -151,000 | -100,000 | |||||||||||||||||||||||||||||||||||||||||
balance at april 1, 2014 | 109,951,000 | ||||||||||||||||||||||||||||||||||||||||||||
balance at june 30, 2014 | 109,951,000 | ||||||||||||||||||||||||||||||||||||||||||||
additions to capitalized software | |||||||||||||||||||||||||||||||||||||||||||||
(payments) loan on csv life insurance policies | |||||||||||||||||||||||||||||||||||||||||||||
see note 2. restatement of previously issued financial statements. | |||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of business | |||||||||||||||||||||||||||||||||||||||||||||
net change in cash and equivalents | 4,172,000 | 1,861,000 | 789,000 | ||||||||||||||||||||||||||||||||||||||||||
cash and equivalents at beginning of period | 0 | 0 | 3,931,000 | ||||||||||||||||||||||||||||||||||||||||||
cash and equivalents at end of period | 4,172,000 | 1,861,000 | 4,720,000 | ||||||||||||||||||||||||||||||||||||||||||
We provide you with 20 years of cash flow statements for Advanced Drainage Systems stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Advanced Drainage Systems stock. Explore the full financial landscape of Advanced Drainage Systems stock with our expertly curated income statements.
The information provided in this report about Advanced Drainage Systems stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.